COVID-19 Up, Oil Prices Down: The Geopolitical Forces Driving the Energy Markets During the Pandemic

 

Steve Hendrickson, President of Ralph E. Davis Associates, has seen his fair share of turmoil in the energy industry over the past 30 years. Still, the culmination of unfolding events these past months may be the most impactful yet.

Hendrickson provided his knowledge and insight to help break down the factors now rocking the energy industry.

Several factors contributed to the issues now facing the oil market, according to Hendrickson. The first is a supply and demand problem. The US produces 11-12 million barrels of oil a day when, several years ago, it generated four million.

And this supply increase doesn’t match up with current demand.

The market softened in 2019, and OPEC began to tighten supply to keep prices steady. In a turnaround, Russia decided to cease giving up market share, which led to more competition with lessening demand. Russia’s ability to withstand the changes in demand better than other OPEC nations fueled the pricing war. Per-barrel prices of oil already dropped roughly $10 before the pandemic hit in force.

“This situation is changing rapidly,” Hendrickson said. “It’s almost hard to respond to the events of yesterday when today brings something new.”

Uncertainty is a killer for the energy market.

“Just a small amount of oversupply, a million to a million and a half barrels, results in a decline of about 30% in spot prices,” Hendrickson said.

With no one knowing how the pandemic would play out and demand dropping in an unprecedented fashion, supply quickly glutted the market, and oil prices crashed. Now, supply is so over-flooded, storage is filling up to capacity.

Hendrickson says oil producers have begun shutting in their wells to reduce production and internal costs and stabilize oil prices. These actions may provide a dampener to the situation, but there are still plenty of unknowns as the world rides out the pandemic.

For the latest insight on the oil and gas industry, head to the Opportune LLP website here.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More